KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Enterprise Value: 2009-2025

Historic Enterprise Value for Dynavax Technologies (DVAX) over the last 17 years, with Sep 2025 value amounting to $516.7 million.

  • Dynavax Technologies' Enterprise Value fell 25.75% to $516.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 billion, marking a year-over-year increase of 2.22%. This contributed to the annual value of $964.8 million for FY2024, which is 9.38% down from last year.
  • Latest data reveals that Dynavax Technologies reported Enterprise Value of $516.7 million as of Q3 2025, which was down 10.53% from $577.5 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Enterprise Value ranged from a high of $1.8 billion in Q3 2021 and a low of $516.7 million during Q3 2025.
  • Over the past 3 years, Dynavax Technologies' median Enterprise Value value was $897.4 million (recorded in 2024), while the average stood at $832.8 million.
  • In the last 5 years, Dynavax Technologies' Enterprise Value skyrocketed by 505.01% in 2021 and then plummeted by 59.01% in 2022.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Enterprise Value stood at $1.1 billion in 2021, then slumped by 35.79% to $733.1 million in 2022, then soared by 45.24% to $1.1 billion in 2023, then dropped by 9.38% to $964.8 million in 2024, then fell by 25.75% to $516.7 million in 2025.
  • Its last three reported values are $516.7 million in Q3 2025, $577.5 million for Q2 2025, and $947.9 million during Q1 2025.